NCT01807533 is a NA clinical trial of Family-centered intervention program in Premature Birth, sponsored by National Taiwan University Hospital.

Who is sponsoring NCT01807533?

NCT01807533 is sponsored by National Taiwan University Hospital.

What drugs are being tested in NCT01807533?

Interventions in NCT01807533: Family-centered intervention program, Usual care intervention program.

What condition does NCT01807533 study?

NCT01807533 studies Premature Birth.

Is NCT01807533 still recruiting?

NCT01807533 is currently completed. Last updated 24 August 2018.

Last reviewed 2018-08-24 · How we verify

NCT01807533

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Family-Centered Intervention Program for Preterm Infants: Effects and Their Biosocial Pathways

Completed NA Last updated 24 August 2018

What this trial tests

NA trial testing Family-centered intervention program in Premature Birth in 275 participants. Completed in 10 January 2017.

Timeline

22 May 2012

Primary endpoint
10 January 2017

10 January 2017

Quick facts

Lead sponsor	National Taiwan University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	275
Start date	22 May 2012
Primary completion	10 January 2017
Estimated completion	10 January 2017
Sites	3 locations across Taiwan

Drugs / interventions tested

Family-centered intervention program
Usual care intervention program

Conditions studied

Premature Birth — all drugs for Premature Birth →

Sponsor

National Taiwan University Hospital

Who can join

Under 36 Weeks, any sex, with Premature Birth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Four hypotheses will be tested in this study: 1. The intervention group performs better in child, parent and transactions outcomes than the control group throughout the follow-up period. 2. The intervention group shows greater changes in early neurophysiological brain functions and transactions within the family that lead to better neurodevelopmental outcomes than the control group. 3. Certain polymorphisms of the dopamine-related genes are associated with the neurodevelopmental outcomes in VLBW preterm infants. 4. Very low birth weight preterm infants carrying more genetic plasticity in the dopamine-related genes may benefit more from the interventions than those carrying less genetic plasticity.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Education of family members to support weaning to solids and nutrition in infants born preterm.
Elfzzani Z, Kwok TC, Ojha S, Dorling J. · · 2019 · cited 6× · PMID 30790274 · DOI 10.1002/14651858.cd012240.pub2
Interaction Between Prematurity and the MAOA Gene on Mental Development in Children: A Longitudinal View.
Yao NJ, Hsieh WS, Lin CH, Tseng CI, et al · · 2020 · cited 2× · PMID 32211356 · DOI 10.3389/fped.2020.00092

Verify or expand the search:

Other recruiting trials for Premature Birth

Currently open trials in the same condition.

NCT07490912 — Neonatal Data and Biobank to Study Factors Influencing Development in Preterm Infants Born at <32 Weeks' Gestation and/o · recruiting
NCT07183462 — Azithromycin and Ampicillin for Late PPROM · Phase 4 · recruiting
NCT07306793 — The Effect of PIOMI and Chronobiological Nutrition on Readiness for Feeding, Full Transition to Oral Feeding and Body We · NA · recruiting
NCT06554522 — Pragmatic Evaluation of Respiratory Distress Syndrome Treatment in Africa · Phase 4 · recruiting
NCT06340971 — Air Pollution and Pregnancy · recruiting

Other National Taiwan University Hospital trials

Trials by the same sponsor.

NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01807533 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
Last refreshed: 24 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01807533.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing